The invention provides compositions and methods for cytosolic delivery of peptides and antigens as well as concomitant delivery of antigens and agonists via poly-norbornene-based protein transduction domain mimics.

To provide a membrane electrode assembly which can suppress cracking of the catalyst layers.

The membrane electrode assembly of the present invention is a membrane electrode assembly comprising an anode having a catalyst layer containing a proton-conductive polymer, a cathode having a catalyst layer containing a proton-conductive polymer, and a polymer electrolyte membrane disposed between the anode and the cathode, wherein the proton-conductive polymer contained in the catalyst layer of at least one of the anode and the cathode is a polymer (H) having units containing a cyclic ether structure and sulfonic acid-type functional groups, and the polymer electrolyte membrane contains a porous material containing a fluorinated polymer, and a fluorinated polymer (S) having sulfonic acid-type functional groups.

To provide a membrane electrode assembly which can suppress cracking of the catalyst layers.

The membrane electrode assembly of the present invention is a membrane electrode assembly comprising an anode having a catalyst layer containing a proton-conductive polymer, a cathode having a catalyst layer containing a proton-conductive polymer, and a polymer electrolyte membrane disposed between the anode and the cathode, wherein the proton-conductive polymer contained in the catalyst layer of at least one of the anode and the cathode is a polymer (H) having units containing a cyclic ether structure and sulfonic acid-type functional groups, and the polymer electrolyte membrane contains a porous material containing a fluorinated polymer, and a fluorinated polymer (S) having sulfonic acid-type functional groups.

The invention relates to a radiation-curable coating composition comprising a 5-hydroxy or 5-alkoxy-2(5H)-furanone compound A, a compound B with two or more vinyl ether or vinyl ester groups, wherein the molar ratio of vinyl moieties in compound B and furanone moieties in compound A is at least 0.5, and wherein the coating composition is free of a compound with two or more acryloyl or methacryloyl groups. The invention further relates to a method of coating a substrate comprising applying such coating composition to a substrate and radiation-curing the coating composition to form a cured coating, and to a coated substrate obtainable by such method.

The invention relates to a radiation-curable coating composition comprising a 5-hydroxy or 5-alkoxy-2(5H)-furanone compound A, a compound B with two or more vinyl ether or vinyl ester groups, wherein the molar ratio of vinyl moieties in compound B and furanone moieties in compound A is at least 0.5, and wherein the coating composition is free of a compound with two or more acryloyl or methacryloyl groups. The invention further relates to a method of coating a substrate comprising applying such coating composition to a substrate and radiation-curing the coating composition to form a cured coating, and to a coated substrate obtainable by such method.

The invention relates to a radiation-curable coating composition comprising a 5-hydroxy or 5-alkoxy-2(5H)-furanone compound A, a compound B with two or more vinyl ether or vinyl ester groups, wherein the molar ratio of vinyl moieties in compound B and furanone moieties in compound A is at least 0.5, and wherein the coating composition is free of a compound with two or more acryloyl or methacryloyl groups. The invention further relates to a method of coating a substrate comprising applying such coating composition to a substrate and radiation-curing the coating composition to form a cured coating, and to a coated substrate obtainable by such method.

A benzoxazine resin composition is provided. The benzoxazine resin composition includes a benzoxazine resin that is a reaction product of an amine, a phenol, and an aldehyde. Either the amine is a diamine or the phenol is a bisphenol, and the benzoxazine resin has at least one nitrogen-containing crosslinking functional group or pyrocitric functional group. A method of preparing a benzoxazine resin composition is also provided. The method includes reacting an amine, a phenol, and an aldehyde at a temperature of above 60° C., for 1 h to 5 days to form a benzoxazine resin. The benzoxazine resin has at least one nitrogen-containing crosslinking functional group or pyrocitric functional group, and either the amine is a diamine or the phenol is a bisphenol. Also provided is a cured resin made from the benzoxazine resin composition.

A benzoxazine resin composition is provided. The benzoxazine resin composition includes a benzoxazine resin that is a reaction product of an amine, a phenol, and an aldehyde. Either the amine is a diamine or the phenol is a bisphenol, and the benzoxazine resin has at least one nitrogen-containing crosslinking functional group or pyrocitric functional group. A method of preparing a benzoxazine resin composition is also provided. The method includes reacting an amine, a phenol, and an aldehyde at a temperature of above 60° C., for 1 h to 5 days to form a benzoxazine resin. The benzoxazine resin has at least one nitrogen-containing crosslinking functional group or pyrocitric functional group, and either the amine is a diamine or the phenol is a bisphenol. Also provided is a cured resin made from the benzoxazine resin composition.

Provided herein are perfluoro copolymers of a perfluoro dioxole monomer, a perfluoro dioxane monomer, and an optional perhalo monomer. Methoda of making the perfluoro copolymers and methods of using the perfluoro copolymers are also disclosed.

Provided herein are perfluoro copolymers of a perfluoro dioxole monomer, a perfluoro dioxane monomer, and an optional perhalo monomer. Methoda of making the perfluoro copolymers and methods of using the perfluoro copolymers are also disclosed.